Aclarion (ACON) vs Advanced Biomed (ADVB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Advanced Biomed is the larger company by market cap ($10.3 million vs $6.8 million), about 1.5 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | ACON | ADVB |
|---|---|---|
| Share price | $2.35 | $6.21 |
| Market cap | $6.77M | $10.26M |
| 1-day change | +2.40% | -2.66% |
| YTD return | — | +6.34% |
| 1-year return | — | -34.77% |
| P/E ratio (TTM) | — | 1.30 |
| EPS (TTM) | $-7.61 | $4.79 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $12.03 | $24.23 |
| 52-week low | $1.95 | $3.61 |
| Distance from 52-week high | -80.47% | -74.37% |
| Average volume | 52.96K | 1.77M |
| Shares outstanding | 2.88M | 1.65M |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
ACON vs ADVB FAQ
Which is bigger, Aclarion or Advanced Biomed?
Advanced Biomed (ADVB) is larger, with a market capitalization of $10.26M compared with $6.77M for Aclarion (ACON).
Are Aclarion and Advanced Biomed in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.